Last updated on February 2019

Clinical Trial to Evaluate the Efficacy Safety and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy


Brief description of study

This is a multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of two different weekly doses of RO7239361 in ambulatory boys with Duchenne Muscular Dystrophy (DMD).

Clinical Study Identifier: NCT03039686

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: WN40227 ...

Hospital Sant Joan De Deu
Esplugues De Llobregas, Spain
5.27miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.